Our studies indicated that there is a high constitutively active AKT (high p-AKT) and ERK1/2 (high p-ERK1/2) in all the three bladder cancer cell lines (Figure 4, Figure S4). The gene discussed is MAPK3; the disease is urinary bladder cancer.